Literature DB >> 27737900

Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.

Pauline D Scanlan1, Anna M Bischofberger2, Alex R Hall3.   

Abstract

Although experiments indicate that the abiotic environment plays an important role in bacterial interactions with their parasitic viruses (bacteriophages or phages), it is not yet clear how exposure to compounds present in nature alters the impact of phages on bacterial growth and evolution. To address this question, we exposed Escherichia coli K12 MG1655, in combination with three lytic phages, to various substances that natural and clinical microbial populations are likely to encounter: bile salts (present in mammalian gastrointestinal tracts), sodium dodecyl sulfate (SDS, a common surfactant in cleaning and hygiene products) and four antibiotics (present at variable concentrations in natural and clinical environments). Our results show that bile salts and SDS can reduce the detrimental effect of phages on bacterial growth. In some cases these compounds completely mitigated any negative effects of phages on bacterial growth and consequently bacteria did not evolve resistance to phages in these conditions. The proportional effects of phages were unaffected by antibiotics in most combinations, excepting three cases of phage-drug synergy. These results suggest that accounting for interactions between phages and environmental factors such as surfactants and antibiotics will improve understanding of both bacterial growth and resistance evolution to phages in vivo and in nature. © FEMS 2016.

Entities:  

Keywords:  Escherichia coli; antibiotics; bacteriophage; bile salts; genotype-by-environment interaction; phage therapy

Mesh:

Substances:

Year:  2016        PMID: 27737900      PMCID: PMC5091284          DOI: 10.1093/femsec/fiw211

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  58 in total

Review 1.  The interaction between bacteria and bile.

Authors:  Máire Begley; Cormac G M Gahan; Colin Hill
Journal:  FEMS Microbiol Rev       Date:  2005-09       Impact factor: 16.408

2.  Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa.

Authors:  Alex R Hall; R Craig MacLean
Journal:  Evolution       Date:  2011-05-10       Impact factor: 3.694

3.  Lytic phages obscure the cost of antibiotic resistance in Escherichia coli.

Authors:  Samuel J Tazzyman; Alex R Hall
Journal:  ISME J       Date:  2015-03-17       Impact factor: 10.302

Review 4.  Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems.

Authors:  Patrick C Phillips
Journal:  Nat Rev Genet       Date:  2008-11       Impact factor: 53.242

5.  Interaction of bacteriophage lambda with its cell surface receptor: an in vitro study of binding of the viral tail protein gpJ to LamB (Maltoporin).

Authors:  Emir Berkane; Frank Orlik; Johannes F Stegmeier; Alain Charbit; Mathias Winterhalter; Roland Benz
Journal:  Biochemistry       Date:  2006-02-28       Impact factor: 3.162

Review 6.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

7.  Viruses' life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages.

Authors:  Marianne De Paepe; François Taddei
Journal:  PLoS Biol       Date:  2006-07       Impact factor: 8.029

8.  Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth.

Authors:  André M Comeau; Françoise Tétart; Sabrina N Trojet; Marie-Françoise Prère; H M Krisch
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

Review 9.  The human gut virome: a multifaceted majority.

Authors:  Lesley A Ogilvie; Brian V Jones
Journal:  Front Microbiol       Date:  2015-09-11       Impact factor: 5.640

10.  Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.

Authors:  Benjamin K Chan; Mark Sistrom; John E Wertz; Kaitlyn E Kortright; Deepak Narayan; Paul E Turner
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  5 in total

1.  Synergistic Effects of Bacteriophage vB_Eco4-M7 and Selected Antibiotics on the Biofilm Formed by Shiga Toxin-Producing Escherichia coli.

Authors:  Agnieszka Necel; Sylwia Bloch; Gracja Topka-Bielecka; Agata Janiszewska; Aleksandra Łukasiak; Bożena Nejman-Faleńczyk; Grzegorz Węgrzyn
Journal:  Antibiotics (Basel)       Date:  2022-05-25

Review 2.  Bacteriophage-Bacteria Interactions in the Gut: From Invertebrates to Mammals.

Authors:  Joshua M Kirsch; Robert S Brzozowski; Dominick Faith; June L Round; Patrick R Secor; Breck A Duerkop
Journal:  Annu Rev Virol       Date:  2021-07-13       Impact factor: 14.263

3.  A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.

Authors:  Tomasz Cieplak; Nitzan Soffer; Alexander Sulakvelidze; Dennis Sandris Nielsen
Journal:  Gut Microbes       Date:  2018-08-24

4.  Genomic, Morphological and Functional Characterization of Virulent Bacteriophage IME-JL8 Targeting Citrobacter freundii.

Authors:  Kaixiang Jia; Nuo Yang; Xiuwen Zhang; Ruopeng Cai; Yang Zhang; Jiaxin Tian; Sayed Haidar Abbas Raza; Yuanhuan Kang; Aidong Qian; Ying Li; Wuwen Sun; Jinyu Shen; Jiayun Yao; Xiaofeng Shan; Lei Zhang; Guiqin Wang
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

Review 5.  Considerations for the Use of Phage Therapy in Clinical Practice.

Authors:  Gina A Suh; Thomas P Lodise; Pranita D Tamma; Jane M Knisely; Jose Alexander; Saima Aslam; Karen D Barton; Erica Bizzell; Katherine M C Totten; Joseph L Campbell; Benjamin K Chan; Scott A Cunningham; Katherine E Goodman; Kerryl E Greenwood-Quaintance; Anthony D Harris; Shayla Hesse; Anthony Maresso; Veronique Nussenblatt; David Pride; Michael J Rybak; Zoe Sund; David van Duin; Daria Van Tyne; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.